211 related articles for article (PubMed ID: 21895989)
21. Complete remission in advanced blastic NK-cell lymphoma/leukemia in elderly patients using the hyper-CVAD regimen.
Shapiro M; Wasik MA; Junkins-Hopkins JM; Rook AH; Vittorio CC; Itakura H; Frankel MC; Georgala S; Schuster SJ
Am J Hematol; 2003 Sep; 74(1):46-51. PubMed ID: 12949889
[TBL] [Abstract][Full Text] [Related]
22. NK and NK-related neoplasms.
Mori N
Nagoya J Med Sci; 1999 Nov; 62(3-4):99-106. PubMed ID: 10689871
[TBL] [Abstract][Full Text] [Related]
23. Blastic natural killer cell lymphoma/leukemia (CD56-positive blastic tumor): prognostication and categorization according to anatomic sites of involvement.
Suzuki R; Nakamura S; Suzumiya J; Ichimura K; Ichikawa M; Ogata K; Kura Y; Aikawa K; Teshima H; Sako M; Kojima H; Nishio M; Yoshino T; Sugimori H; Kawa K; Oshimi K;
Cancer; 2005 Sep; 104(5):1022-31. PubMed ID: 15999368
[TBL] [Abstract][Full Text] [Related]
24. Cutaneous T-cell and NK-cell lymphomas: the WHO-EORTC classification and the increasing recognition of specialized tumor types.
Kinney MC; Jones D
Am J Clin Pathol; 2007 May; 127(5):670-86. PubMed ID: 17439828
[TBL] [Abstract][Full Text] [Related]
25. [Malignant lymphoma and leukemia concepts in new WHO classification].
Kikuchi M
Rinsho Byori; 2003 Aug; 51(8):820-4. PubMed ID: 13677944
[TBL] [Abstract][Full Text] [Related]
26. The World Health Organization (WHO) classification of tumors of the hematopoietic and lymphoid tissues: an overview with emphasis on the myeloid neoplasms.
Vardiman JW
Chem Biol Interact; 2010 Mar; 184(1-2):16-20. PubMed ID: 19857474
[TBL] [Abstract][Full Text] [Related]
27. [NK-cell lymphomas and NK-like T-cell lymphomas].
Oshimi K
Nihon Rinsho; 2000 Mar; 58(3):646-9. PubMed ID: 10741139
[TBL] [Abstract][Full Text] [Related]
28. Cytotoxic/natural killer cell cutaneous lymphomas. Report of EORTC Cutaneous Lymphoma Task Force Workshop.
Santucci M; Pimpinelli N; Massi D; Kadin ME; Meijer CJ; Müller-Hermelink HK; Paulli M; Wechsler J; Willemze R; Audring H; Bernengo MG; Cerroni L; Chimenti S; Chott A; Díaz-Pérez JL; Dippel E; Duncan LM; Feller AC; Geerts ML; Hallermann C; Kempf W; Russell-Jones R; Sander C; Berti E;
Cancer; 2003 Feb; 97(3):610-27. PubMed ID: 12548603
[TBL] [Abstract][Full Text] [Related]
29. The World Health Organization classification of malignant lymphoma: incidence and clinical prognosis in HTLV-1-endemic area of Fukuoka.
Ohshima K; Suzumiya J; Kikuchi M
Pathol Int; 2002 Jan; 52(1):1-12. PubMed ID: 11940200
[TBL] [Abstract][Full Text] [Related]
30. An aggressive extranodal NK-cell lymphoma arising from indolent NK-cell lymphoproliferative disorder.
Huang Q; Chang KL; Gaal KK; Weiss LM
Am J Surg Pathol; 2005 Nov; 29(11):1540-3. PubMed ID: 16224224
[TBL] [Abstract][Full Text] [Related]
31. Natural killer cell neoplasm: biology and pathology.
Ham MF; Ko YH
Int J Hematol; 2010 Dec; 92(5):681-9. PubMed ID: 21132576
[TBL] [Abstract][Full Text] [Related]
32. Blastic NK-cell-like lymphoma with T-cell receptor gene rearrangement.
Liu XY; Atkins RC; Feusner JH; Rowland JM
Am J Hematol; 2004 Apr; 75(4):251-3. PubMed ID: 15054822
[TBL] [Abstract][Full Text] [Related]
33. Lymphoproliferative disorder of granular lymphocytes: nine cases including one with features of CD56 (NKH1)-positive aggressive natural killer cell lymphoma.
Nichols GE; Normansell DE; Williams ME
Mod Pathol; 1994 Oct; 7(8):819-24. PubMed ID: 7530849
[TBL] [Abstract][Full Text] [Related]
34. Blastic natural killer cell leukemia/lymphoma presenting as overt leukemia.
Alvarez-Larrán A; Villamor N; Hernández-Boluda JC; Ferrer A; Camós M; Campo E; López-Guillermo A
Clin Lymphoma; 2001 Dec; 2(3):178-82; discussion 183-4. PubMed ID: 11779295
[TBL] [Abstract][Full Text] [Related]
35. Relative frequency of the different types of cutaneous T cell and natural killer cell lymphomas in Korea based on the proposed WHO classification and the EORTC classification.
Chang SE; Jee MS; Kim KJ; Choi JH; Sung KJ; Moon KC; Koh JK
J Dermatol; 2003 Jan; 30(1):42-7. PubMed ID: 12598708
[TBL] [Abstract][Full Text] [Related]
36. Natural killer cell lymphoma/leukemia: pathology and treatment.
Kwong YL; Chan AC; Liang RH
Hematol Oncol; 1997 May; 15(2):71-9. PubMed ID: 9375032
[TBL] [Abstract][Full Text] [Related]
37. The spectrum of cutaneous lymphomas in Japan: a study of 62 cases based on the World Health Organization Classification.
Yasukawa K; Kato N; Kodama K; Hamasaka A; Hata H
J Cutan Pathol; 2006 Jul; 33(7):487-91. PubMed ID: 16872471
[TBL] [Abstract][Full Text] [Related]
38. Childhood blastic NK cell leukemia successfully treated with L-asparagenase and allogeneic bone marrow transplantation.
Hyakuna N; Toguchi S; Higa T; Okudaira T; Taira N; Masuda M; Kitoh T; Ohta T
Pediatr Blood Cancer; 2004 Jun; 42(7):631-4. PubMed ID: 15127419
[TBL] [Abstract][Full Text] [Related]
39. NK-cell neoplasms in Japan.
Oshimi K; Kawa K; Nakamura S; Suzuki R; Suzumiya J; Yamaguchi M; Kameoka J; Tagawa S; Imamura N; Ohshima K; Kojya S; Iwatsuki K; Tokura Y; Sato E; Sugimori H;
Hematology; 2005 Jun; 10(3):237-45. PubMed ID: 16019472
[TBL] [Abstract][Full Text] [Related]
40. Precursor natural killer cell leukemia.
Liang X; Greffe B; Garrington T; Graham DK
Pediatr Blood Cancer; 2008 Apr; 50(4):876-8. PubMed ID: 17417789
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]